Randomized clinical stroke trials in 2006. Review uri icon

Overview

abstract

  • This article reviews randomized control trials (RCT's) published in 2006 of various medications evaluated for stroke patients. These trials were primarily efficacy studies. These included aggrenox (an antiplatelet agent), magnesium (to treat arterial spasm after an aneurysmal subarachnoid hemorrhage), NXY (a free radical trapping agent) and albumin which were both tested as a neuroprotectant, amphetamine (to aid motor recovery), fluoxetine (an anti-depressant and anxiolytic) and low molecular weight heparin (for prevention of deep vein thrombosis post-stroke).

publication date

  • January 1, 2008

Research

keywords

  • Stroke

Identity

Scopus Document Identifier

  • 43249103204

Digital Object Identifier (DOI)

  • 10.2174/157016108783331259

PubMed ID

  • 18220941

Additional Document Info

volume

  • 6

issue

  • 1